Wyszukano: Octan+1-fenyloetylu

1 429 wyniki/ów wyszukiwania

Doprecyzuj wyniki Sortuj

Sort Results

Widok listy Widok uproszczony (nowość)

Porównaj(0) Wyczyść

Oceń wyniki wyszukiwania

octan potasu 99.0-100.5% (dried basis), granular USP, Multi-Compendial endotoxin tested, J.T.Baker®

Producent: Avantor

Opis: octan potasu 99.0-100.5% (dried basis), granular USP, Multi-Compendial endotoxin tested, J.T.Baker®

MSDS Certyfikaty

octan rtęci (II) 99+%

Producent: Thermo Fisher Scientific

Opis: octan rtęci (II) 99+%

MSDS

Octan 2-butoksyetylu 98%

Producent: Thermo Fisher Scientific

Opis: Octan 2-butoksyetylu 98%

MSDS

Octan fenylu 97%

Producent: Apollo Scientific

Opis: Octan fenylu 97%

Octan fenylu 97%

Producent: Thermo Fisher Scientific

Opis: Octan fenylu 97%

MSDS

octan sodu in aqueous solution USP Test Solution (TS) 34

Numer katalogowy: (85371.260)

Producent: VWR Chemicals

Opis: Ready to use test solutions (TS).

j.m.: 1 * 500 mL

MSDS Certyfikaty Wyprzedaż

- -

Octan 2-bromoetylu 97%

Numer katalogowy: (APOSOR904265-500G)

Producent: Apollo Scientific

Opis: Octan 2-bromoetylu 97%

j.m.: 1 * 500 g

Wyprzedaż

- -

WYE-125132 ≥98%, crystalline solid

Producent: Cayman Chemical

Opis: WYE-125132 is an ATP-competitive inhibitor of mTOR (IC50 = 0,19 nM) that inhibits signaling through both mTORC1 and mTORC2. It is selective for mTOR over phosphatidylinositol 3-kinase isoforms. WYE-125132 is effective against mTORC1 and mTORC2 in diverse cancer models, both in vitro and in vivo. Oral administration of WYE-125132 alone blocks mTOR signaling and prevents tumor growth in breast, lung, renal, and glioma cancer xenografts in mice, while combination therapy with the VEGF-inhibitor bevacizumab causes complete regression of A498 renal carcinoma tumors. In addition to its applications in cancer, WYE-125132 has been used to delineate novel aspects of mTOR signaling.